Elite Pharmaceuticals, Inc. (ELTP)
| Market Cap | 50.46M |
| Revenue (ttm) | 25.38M |
| Net Income (ttm) | 5.09M |
| Shares Out | 1.01B |
| EPS (ttm) | 0.01 |
| PE Ratio | 9.90 |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | July 28 |
| Last Price | $0.0495 |
| Previous Close | $0.0500 |
| Change ($) | -0.0005 |
| Change (%) | -1.00% |
| Day's Open | 0.0470 |
| Day's Range | 0.0470 - 0.0500 |
| Day's Volume | 86,004 |
| 52-Week Range | 0.0400 - 0.0900 |
Conference Call Scheduled for Tuesday, June 15 at 11:30 AM EDT NORTHVALE, NJ / ACCESSWIRE / June 14, 2021 / Elite Pharmaceuticals, Inc. ('Elite' or the "Company')(OTCBB:ELTP), a specialty pharmaceutical...
Financials for Fiscal Year Ended March 31, 2021 will be released June 14, 2021 NORTHVALE, NJ / ACCESSWIRE / June 8, 2021 / Elite Pharmaceuticals, Inc. ('Elite' or the "Company') (OTCBB:ELTP), a specialt...
NORTHVALE, NJ / ACCESSWIRE / May 4, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today that its distribution and marketing partner Prasco, LLC ("Prasco"), has lau...
NORTHVALE, NJ / ACCESSWIRE / April 29, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche generic products,...
NORTHVALE, NJ / ACCESSWIRE / January 5, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche generic products...
About ELTP
Elite Pharmaceuticals, Inc. engages in the research, development, manufacture, and licensing of proprietary orally administered controlled-release drug delivery systems and products. The company operates in two segments, Abbreviated New Drug Applications for Generic Products and New Drug Applications for Branded Products. It owns, licenses, and contract manufactures various generic and oral dose pharmaceuticals products, such as Phentermine HCl 37.5mg tablets for the treatment of bariatrics under Adipex-P brand; Hydromorphone HCl 8mg tablets fo... [Read more...]
| Industry Drug Manufacturers-Specialty & Generic | IPO Date Jul 23, 1998 |
| Stock Exchange OTCMKTS | Ticker Symbol ELTP |